| Document |
Document Title |
|
WO/2005/009448A1 |
The invented remedy allows cleaning up the area from necrotic tissues and facilitating reduced perifocal oedema and infiltration as well as lessening pain syndrome during suppurative inflammation diseases. The remedy can be applied both ...
|
|
WO/2005/010164A2 |
Polymers that are biocompatible are useful for various medical purposes such as tissue repair, reconstruction and wound healing. A method and composition for producing a biocompatible polymer formed from nucleic acids is disclosed. The n...
|
|
WO/2005/007717A1 |
A process for preparing a thermosensitive polymer from a microemulsion is provided. The microemulsion comprises a monomer capable of forming a thermosensitive polymer and a polymerizable surfactant. Additional comonomers may be included ...
|
|
WO/2005/002510A2 |
This invention relates to deployable hemostatic materials comprising chitosan fibers upon which hemostatic microporous polysaccharide microspheres and a medicament or biologically active substance are deposited. The hemostatic materials ...
|
|
WO/2004/112854A1 |
This invention includes malleable, biodegradable, fibrous compositions for application to a tissue site in order to promote or facilitate new tissue growth. One aspect of this invention is a fibrous component that provides unique mechani...
|
|
WO/2004/110511A1 |
A wound care device for local treatment of pain in a wound, said device comprising an active pain relieving composition, the device being constructed in such a manner that the pain killing agent is released to the wound in such a way tha...
|
|
WO/2004/110420A1 |
The present invention provides a method for treating or preventing excessive scarring, including keloid and hypertrophic scars, by administering 4-hydroxy tamoxifen to a patient with excessive scarring or a wound at risk for developing e...
|
|
WO/2004/108175A1 |
The present invention relates to a preparation for application to the skin (stratum corneum). According to the invention, the preparation comprises a silicone composition which is highly viscous on application and which, after applicatio...
|
|
WO/2004/105821A1 |
A substantially water-free scar management composition in the form of a liquid gel. The composition comprises at least one silicone elastomer and/or gum.
|
|
WO/2004/094457A2 |
Disclosed herein are a chemical composition of 2-amino-6-[(2-amino-5 &lcub guanidine&rcub pentanoyl) amino] hexanoic acid (AAGPAHA) and a method of making it. The pharmaceutical composition includes AAGPAHA and a pharmaceutical excipient...
|
|
WO/2004/089430A1 |
This invention discloses a new kind of dressing material and an application of the dressing material in skin wound treatment. The dressing material can promote proliferation of the epithelial cells. The material comprises inorganic Si an...
|
|
WO/2004/085508A1 |
The present invention provides compositions that may be useful, inter alia, in medical procedures, methods for making such compositions, and methods of performing medical procedures using such compositions. The present invention further ...
|
|
WO/2004/080500A1 |
A wound dressing material comprising a low-moisture hydrocolloid matrix having oxidized cellulose distributed therein. For example, a matrix of dried sodium carboxymethylcelIulose gel having fibers of oxidized regenerated cellulose dispe...
|
|
WO/2004/078165A1 |
A cataplasm base that exhibits a high water content, having adherent and shape retaining properties and is free from paste seepage and that avoids skin irritation and can be cleanly detached from the skin without paste residue; and a cat...
|
|
WO/2004/073697A1 |
The specification discloses an alginate foam composition dressing which may be prepared with or without a backing. The foam dressing exhibits unique capability in including soluble or insoluble medicaments a s part of the alginate foam c...
|
|
WO/2004/064882A1 |
An anhydrous, hydrophilic superabsorbent wound dressing of a viscosity capable of being containd in, and expelled from a dispensing tube, comprising: an anhydrous, hydrophilic gel base carrier selected from the group of poloxamers and po...
|
|
WO/2004/061976A1 |
In some embodiments, non-volatile memory (NVM) devices (23) are formed on a silicon-on-insulator (SOI) substrate (12) by forming elevated sources and drains (56) in contact with extensions (46) within the top silicon layer (18) of the SO...
|
|
WO/2004/060172A1 |
The present invention relates generally to the field of hemostasis, including methods, compositions, and devices that can be employed to achieve hemostasis at an increased rate. More specifically the present invention relates to hemostat...
|
|
WO/2004/058315A1 |
The invention relates to a self-adhesive matrix comprising a polymer, preferably a polyacrylic acid polymer, which is formed in water, sea algae extract, and a monovalent or polyvalent alcohol. The inventive matrix can be doped with hydr...
|
|
WO/2004/054632A1 |
The invention relates to a composition for the dressing of wounds in the form of a liquid and/or a gel, comprising a synthetic catalyst which promotes blood coagulation, selected from the group of pharmacologically-acceptable acids or ly...
|
|
WO/2004/052336A2 |
The present invention relates to novel nonpolymeric compounds and compositions that form liquid, high viscosity materials suitable for the delivery of biologically active substances in a controlled fashion, and for use as medical or surg...
|
|
WO/2004/048449A2 |
A process for manufacturing a fibrin membrane from blood plasma that was partially depleted and subjected to coagulation by adding a solution of a physiological coagulating agent, leaving the mixture to stay until forming a gelatinous bl...
|
|
WO/2004/039421A1 |
Disclosed is a polyurethane foam dressing for a wound filler, which includes a hydrophilic polyurethane foam including a plurality of open cells with a diameter of 50 to 400 µm and a plurality of pores with a diameter of 10 to 80 µm, a...
|
|
WO/2004/037307A1 |
A wound dressing composition comprising a partially cured polyurethane fluid. The composition can be injected directly into a wound, where it cures to form a wound filling dressing. Also provided is a wound dressing comprising such a com...
|
|
WO/2004/032862A2 |
The application discloses cyclodextrin-modified materials for carrying drugs and other active agents, such as nucleic acids. Compositions are also disclosed of cyclodextrin-modified materials that release such active agents under control...
|
|
WO/2004/029137A2 |
Functionalized chrondroitin sulfate, cross-linked polymer matrices comprising functionalized chrondroitin sulfate, and methods of making and using the same are provided. Such polymer matrices may be used for tissue engineering, reconstru...
|
|
WO2003086491B1 |
Tissue defect dressing comprising a proteinaceous salve comprising water soluble keratin molecules networked by inter-protein associations comprising covalent bonds between keratin melecules comprised primarily of bonds other than disulf...
|
|
WO/2004/026259A2 |
The present invention is directed to transdermal compositions and the users thereof. These compositions include at least one of the following components: a C1-C6 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organ...
|
|
WO/2004/024197A1 |
The invention provides a wound dressing material comprising a complex of an anionic polysaccharide with silver, wherein the material comprises from about 0.1wt. % to about 3wt. % of silver. Also provided are wound dressings comprising su...
|
|
WO/2004/024198A1 |
An activator for forming autologous platelet gel, platelet poor plasma gel or platelet rich plasma gel is described comprising a solution containing batroxobin and a calcium salt, characterised in that said solution contains essentially ...
|
|
WO/2004/022077A1 |
The present invention provides the use and composition of matter of angiogenic or other growth/cytokine factors expressed by mixtures of allogeneic human cell strains or lines of various types and stages of differentiation. Also provided...
|
|
WO2002089675A9 |
A wound closure system and methods utilizes a patient's own blood. The system preferably includes a chamber with a needle and a plunger for transferring and storing blood prior to surgery and the use of reversible anticoagulants. The cha...
|
|
WO/2004/006972A1 |
A composition comprising a non-volatile silicone fluid in admixture with fumed silica, a volatile diluent and a silicone elastomer.
|
|
WO/2004/003034A1 |
The present invention relates to polymerized hydrogels and processes to make such hydrogels, in particular hydrogel adhesives which are capable of attaching to mammalian skin and can be used in various personal care products, such as was...
|
|
WO/2004/002539A2 |
The present invention is related to a sealant or a tissue generating product comprising a (coagulated) plasma matrix, one or more growth factors, at least one phospholipid and a protein scatffold for the generation of said tissue (or the...
|
|
WO/2003/101404A2 |
The present invention is related to topical preparations for release of an active agent and to methods of making and using the topical preparations. The preparations may have an internal phase dispersed within an external phase. The inte...
|
|
WO/2003/101501A1 |
The invention relates to a multi-layer collagen article useful for wound healing, comprising at least two layers; wherein at least one layer, facing the wound side, is comprising an effective amount of non or partially cross-linked colla...
|
|
WO/2003/099181A1 |
Methods and systems for closing wounds using wound closures and a flowable adhesive skin paint are disclosed. The flowable adhesive does not adhere the wound closures to the skin over the wound to reduce irritation. In some embodiments, ...
|
|
WO/2003/097116A1 |
A cross-linked plasticised polymeric hydrogel suitable for use in mammalian body tissue (e.g. skin) contacting applications, which comprises a cross-linked copolymer formed from a first monomer comprising one or more pendant anionic grou...
|
|
WO/2003/092634A2 |
The invention provides a topical composition which includes at least Butylated Hydroxy Toluenne, Marula Oil, Alpha Tocopherol Acetate, Vitamin A Palmitate, Tea Tree Oil, Propyl-p-hydroxybenzoate, Pteroyl Glutamic Acid, collagen, placento...
|
|
WO/2003/090765A1 |
It is intended to provide medicinal compositions which are advantageous as sealants for wound, etc. and have an effect of strongly promoting the healing of intractable wounds or operative wounds without any risk of side effects such as c...
|
|
WO/2003/086234A2 |
A non-woven fiber assembly comprises one or more fibers containing an adhesive component, an elastomeric component, and a hydrophilic component. A method of making a non-woven fiber assembly comprises the steps of providing one or more f...
|
|
WO/2003/087197A1 |
Networks, hydrogels, and methods for networks and hydrogels comprising proteinaceous material consisting essentially of water soluble proteins and covalent interprotein crosslinks other than disulfide crosslinks.
|
|
WO/2003/087156A2 |
Methods for producing biocompatible heterogeneous proteinaceous networks crosslinked with a heterogeneous crosslinking agent, and the novel crosslinked networks.
|
|
WO/2003/087195A2 |
Methods for producing biocompatible heterogeneous proteinaceous networks crosslinked with a heterogeneous crosslinked agent, and novel heterogeneous crosslinked networks. Said heterogeneous crosslinking agents are silicone-based.
|
|
WO/2003/082358A1 |
The invention relates to the use of glass and/or glass ceramics in the form of powder and/or fibers having a total glass composition that comprises at least one ion that is released in an aqueous solution. The invention is characterized ...
|
|
WO/2003/082914A1 |
The invention relates to snake venom protease polypeptides and nucleic acid sequences encoding same. This invention also relates to methods of making and using the snake venom proteases, e.g., to promote haemostasis and prevent blood los...
|
|
WO/2003/082163A1 |
The present invention relates to drug delivery devices for moist tissue, in particular mucosal tissue and tissue in the serous cavities, as well as a method of its use. The devices, which contain NOCC, are adherent to the mucosal tissue,...
|
|
WO/2003/077964A1 |
The invention provides absorbent hydrogel compositions and hydrogel-containing structures. Typically, a first portion of the novel materials comprises a porous flexible plasticised hydrophilic polymer matrix having an internal cellular s...
|
|
WO/2003/075970A1 |
The protective film with enhanced adhesion to the skin constitutes of a modified compound on the basis of a alcoholic polyvinilalchol solution of the following proportion: 1 to 50 weight perc. of polyvinilalcohol, 5 to 70 weight perc. of...
|
